Immediate Impact

1 by Nobel laureates 1 from Science/Nature 94 standout
Sub-graph 1 of 18

Citing Papers

Advances in diagnosis and treatment of bladder cancer
2024 Standout
Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
2024 Standout
12 intermediate papers

Works of V. Chantada being referenced

Sequential Combination of Mitomycin C Plus Bacillus Calmette-Guérin (BCG) Is More Effective but More Toxic Than BCG Alone in Patients with Non–Muscle-invasive Bladder Cancer in Intermediate- and High-risk Patients: Final Outcome of CUETO 93009, a Randomized Prospective Trial
2014
A Multicentre, Randomised Prospective Trial Comparing Three Intravesical Adjuvant Therapies for Intermediate-Risk Superficial Bladder Cancer: Low-Dose Bacillus Calmette-Guerin (27 mg) versus Very Low-Dose Bacillus Calmette-Guerin (13.5 mg) versus Mitomycin C
2007

Author Peers

Author Last Decade Papers Cites
V. Chantada 253 102 84 17 316
J.J. Patard 173 106 53 24 261
J. A. CUMMING 147 70 88 20 291
Victor Lane 237 128 57 23 325
David Golombos 145 76 110 23 333
Chih‐Hsiung Kang 281 57 111 17 371
A. Jurczok 221 31 85 15 342
Akihiko Aoki 132 29 70 25 268
Keita Minami 220 91 58 27 357
Jake Patterson 201 25 79 18 348
Sumit Isharwal 288 31 82 13 352

All Works

Loading papers...

Rankless by CCL
2026